You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKinsey
Baxter
Moodys
Johnson and Johnson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Ziprasidone mesylate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ziprasidone mesylate and what is the scope of freedom to operate?

Ziprasidone mesylate is the generic ingredient in two branded drugs marketed by Pfizer and Gland Pharma Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for ziprasidone mesylate. Four suppliers are listed for this compound.

Recent Clinical Trials for ziprasidone mesylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 4
Yang FudePhase 4

See all ziprasidone mesylate clinical trials

Pharmacology for ziprasidone mesylate

US Patents and Regulatory Information for ziprasidone mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd ZIPRASIDONE MESYLATE ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 211908-001 Dec 26, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ziprasidone mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002   Start Trial   Start Trial
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002   Start Trial   Start Trial
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002   Start Trial   Start Trial
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKinsey
Baxter
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.